Gabriel Rozenberg - Raia Drogasil IR Director

RADLY Stock  USD 4.70  0.96  25.67%   

Insider

Gabriel Rozenberg is IR Director of Raia Drogasil SA
Phone55 11 3769 5678
Webhttps://www.rd.com.br

Raia Drogasil Management Efficiency

The company has return on total asset (ROA) of 0.0667 % which means that it generated a profit of $0.0667 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1825 %, meaning that it generated $0.1825 on every $100 dollars invested by stockholders. Raia Drogasil's management efficiency ratios could be used to measure how well Raia Drogasil manages its routine affairs as well as how well it operates its assets and liabilities.
Raia Drogasil SA has accumulated 891.39 M in total debt with debt to equity ratio (D/E) of 1.21, which is about average as compared to similar companies. Raia Drogasil SA has a current ratio of 1.54, which is within standard range for the sector. Debt can assist Raia Drogasil until it has trouble settling it off, either with new capital or with free cash flow. So, Raia Drogasil's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Raia Drogasil SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Raia to invest in growth at high rates of return. When we think about Raia Drogasil's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Aaron RadeletWalgreens Boots Alliance
N/A
Rebecca WarnerLeafly Holdings
N/A
Monica Mu111 Inc
N/A
Carlos PintoLeafly Holdings
N/A
Jeff OberlanderLeafly Holdings
N/A
Junling Liu111 Inc
59
David CotterLeafly Holdings
53
Mia ScholzWalgreens Boots Alliance
58
Haihui Wang111 Inc
N/A
Holly MayWalgreens Boots Alliance
42
Pengcheng Zhu111 Inc
N/A
Harkirat GroverHigh Tide
42
Matthew HulettPetMed Express
53
Daniel PingreePetMed Express
N/A
Suresh KrishnaswamyLeafly Holdings
55
Joy AvzarHigh Tide
N/A
Deidre BoulwareLeafly Holdings
N/A
Danielle GrayWalgreens Boots Alliance
45
Aman SoodHigh Tide
N/A
Laura MorarityLeafly Holdings
N/A
Neal MillerSunLink Health Systems
N/A
Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. The company was founded in 1905 and is headquartered in So Paulo, Brazil. RAIA DROGASIL operates under Pharmaceutical Retailers classification in the United States and is traded on OTC Exchange. It employs 50320 people. Raia Drogasil SA [RADLY] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Raia Drogasil SA Leadership Team

Elected by the shareholders, the Raia Drogasil's board of directors comprises two types of representatives: Raia Drogasil inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Raia. The board's role is to monitor Raia Drogasil's management team and ensure that shareholders' interests are well served. Raia Drogasil's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Raia Drogasil's outside directors are responsible for providing unbiased perspectives on the board's policies.
Eugnio Zagottis, IR, Planning
Antonio Coelho, CFO, Member of the Executive Board
Ligia Mendes, Controllership charge
Fernando Varela, Chief Technology and Logistics Officer, Member of the Executive Board
Maria Souza, Director of Human Resources, Member of the Executive Board
Gabriel Rozenberg, IR Director
Renato Raduan, Director of Retail Operations, Member of the Executive Board
Bruno Pipponzi, VP Board
Marcello Zagottis, Chief Marketing, Sales and Commercial Officer, Member of the Executive Board
Marclio Pousada, CEO Board

Raia Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Raia Drogasil a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Raia Pink Sheet Analysis

When running Raia Drogasil's price analysis, check to measure Raia Drogasil's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Raia Drogasil is operating at the current time. Most of Raia Drogasil's value examination focuses on studying past and present price action to predict the probability of Raia Drogasil's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Raia Drogasil's price. Additionally, you may evaluate how the addition of Raia Drogasil to your portfolios can decrease your overall portfolio volatility.